EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside

Yiming Luo, Ye Yuan, Dan Liu, Haoxin Peng, Lin Shen, Yang Chen

Trends in Cancer · 2025-06 · 11 (6) · 540-559

DOI: 10.1016/j.trecan.2025.02.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-06. Verfasst von Yiming Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking Univers…. Hauptthemen laut MEDLINE: Neoplasms, B7 Antigens, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Science and Technology Planning Project, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The B7-H family of immune checkpoint molecules is a crucial component of the immune regulatory network for tumors, offering new opportunities to modulate the tumor microenvironment (TME). The B7-H family - which includes B7-H2 (inducible T cell costimulatory ligand, ICOSL), B7-H3, B7-H4, B7-H5 (V-domain immunoglobulin suppressor of T cell activation, VISTA), B7-H6, and B7-H7 (HHLA2) - is known for its diverse roles in regulating innate and adaptive immunity. These molecules can exhibit co-stimulatory or co-inhibitory effects on T cells, influencing processes such as T cell activation, differentiation, and effector functions, and they are involved in the recruitment and polarization of various immune cells. This review explores the structural characteristics, receptor-ligand interactions, and signaling pathways associated with each B7-H family member. We also discuss the family's impact on tumor immunity and potential therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsB7 AntigensImmunotherapyImmune Checkpoint InhibitorsHumansTumor MicroenvironmentAnimalsSignal TransductionInducible T-Cell Co-Stimulator LigandT-LymphocytesLymphocyte Activation

Stichwörter der Autor:innen

B7-H familycancer immunotherapyimmune checkpointstumor microenvironment

Substanzen

B7 AntigensImmune Checkpoint InhibitorsInducible T-Cell Co-Stimulator Ligand

Autor:innen und Institutionen

  • Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Early Drug Development Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address:…
  • Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China; Department of Gastr…

Förderung

  • Beijing Science and Technology Planning Project
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Fundamental Research Funds for the Central Universities
  • Beijing Hospital Authority
  • Beijing Xisike Clinical Oncology Research Foundation
  • Natural Science Foundation of Beijing Municipality
  • Peking University

Zitieren

APA

Luo, Y., Yuan, Y., Liu, D., Peng, H., Shen, L., & Chen, Y. (2025). Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside. Trends in Cancer, 11(6), 540-559. https://doi.org/10.1016/j.trecan.2025.02.007

Vancouver

Luo Y, Yuan Y, Liu D, Peng H, Shen L, Chen Y. Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside. Trends in Cancer. 2025;11(6):540-559. doi:10.1016/j.trecan.2025.02.007

BibTeX
@article{Luo2025,
  author = {Luo, Yiming and Yuan, Ye and Liu, Dan and Peng, Haoxin and Shen, Lin and Chen, Yang},
  title = {Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {6},
  pages = {540--559},
  doi = {10.1016/j.trecan.2025.02.007}
}
Kostenlos starten →